Acta Med. 2026, 69: 32-36
https://doi.org/10.14712/18059694.2026.14
Growth Hormone-Mediated Diabetic Ketoacidosis: A Rare Presentation of Acromegaly
Waraporn Polamuanga, Thanyaporn Angsuwatcharakornb,c, Sakun Santisukwongchoted, Sarat Sunthornyothinb,e, Thiti Snabboonb,e
aDepartment of Medicine, Prapokklao Hospital, Chanthaburi province, Thailand
bDepartment of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
cDepartment of Medicine, Somdet Phra Phutthaloetla Hospital, Samut Songkhram province, Thailand
dDepartment of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
eExcellence Centre in Diabetes, Hormone and Metabolism, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
Received September 10, 2025
Accepted March 6, 2026
References
1. A, Grasso LFS, Giustina A, et al. Acromegaly. Nat Rev Dis Primers. 2019; 5: 20.
<https://doi.org/10.1038/s41572-019-0071-6>
2. MR, Kasuki L, Lim DST, Fleseriu M. Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev. 2019; 40: 268–332.
<https://doi.org/10.1210/er.2018-00115>
3. F, Albani A, Ciresi A, Giordano C, Cannavò S. Diabetes secondary to acromegaly: physiopathology, clinical features and effects of treatment. Front Endocrinol (Lausanne). 2018; 9: 358.
<https://doi.org/10.3389/fendo.2018.00358>
<PubMed>
4. PW. Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population. Pituitary. 2011; 14: 217–21.
<https://doi.org/10.1007/s11102-010-0281-0>
5. K, Fukuoka H, Iguchi G, et al. The prevalence of acromegaly in hospitalized patients with type 2 diabetes. Endocr J. 2015; 62: 53–9.
<https://doi.org/10.1507/endocrj.EJ14-0254>
6. D, Boguszewski CL, Colao A, et al. Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management. Nat Rev Endocrinol. 2024; 20: 541–52.
<https://doi.org/10.1038/s41574-024-00993-x>
7. P, Sunthornyothin S, Siwanuwatn R, et al. Clinical characteristics and treatment outcomes in acromegaly, a retrospective single-center case series from Thailand. Pan Afr Med J. 2021; 40: 31.
<https://doi.org/10.11604/pamj.2021.40.31.29920>
<PubMed>
8. JJ, Nilavar S, Post KD, Freda PU. Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. J Clin Endocrinol Metab. 2005; 90: 1972–8.
<https://doi.org/10.1210/jc.2004-2009>
9. N, Goto H, Suzuki H, et al. Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute. Eur J Endocrinol. 2013; 169: 127–32.
<https://doi.org/10.1530/EJE-13-0060>
10. M, Paschou SA, Xekouki P, et al. Secondary diabetes mellitus in acromegaly. Endocrine. 2023; 81: 1–15.
<https://doi.org/10.1007/s12020-023-03339-1>
<PubMed>
11. T, Sarat S. Clinical characteristics and long-term follow-up of ketosis-prone diabetes in Thai patients. Exp Clin Endocrinol Diabetes. 2014; 122: 303–7.
12. PW, Calsolari MR. Safety and specificity of the growth hormone suppression test in patients with diabetes. Endocrine. 2014; 48: 329–33.
<https://doi.org/10.1007/s12020-014-0282-2>
13. G, Niwattisaiwong S, Bena JF, et al. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism? Endocrine. 2019; 64: 139–46.
<https://doi.org/10.1007/s12020-018-1805-z>
14. MG, Giorgino F, Pezzino V, Scaroni C, Avogaro AJ. Italian Society for the Study of Diabetes (SID) / Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushingʼs syndrome and acromegaly. J Endocrinol Invest. 2016; 39: 235–55.
<https://doi.org/10.1007/s40618-015-0404-6>
15. S, di Filippo L, Fleseriu M, et al. Consensus on acromegaly therapeutic outcomes: an update. Nat Rev Endocrinol. 2025 Nov; 21(11): 718–37.
<https://doi.org/10.1038/s41574-025-01148-2>
16. SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol. 2022; 33: 6–26.
<https://doi.org/10.1007/s12022-022-09703-7>
